Auld, S.CMaenetje, PRavimohan, SWeissman, DNcube, IMlotshwa, MRatsela, NChase, WVangu, M.DWallis, RChurchyard, GKornfeld, HBisson, G.P2024-10-022024-10-022019-09-25Auld SC, Maenetje P, Ravimohan S, Weissman D, Ncube I, Mlotshwa M, Ratsela N, Chase W, Vangu MD, Wallis R, Churchyard G, Kornfeld H, Bisson GP. Declines in Lung Function After Antiretroviral Therapy Initiation in Adults With Human Immunodeficiency Virus and Tuberculosis: A Potential Manifestation of Respiratory Immune Reconstitution Inflammatory Syndrome. Clin Infect Dis. 2020 Apr 10;70(8):1750-1753. doi: 10.1093/cid/ciz733.https://doi.org/10.1093/cid/ciz733https://pubmed.ncbi.nlm.nih.gov/31552412/https://doi.org/10.1093/cid/ciz733https://hdl.handle.net/11288/597661End-organ impairment has received relatively little research attention as a possible manifestation of tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS). In this prospective cohort study, one-half of adults with human immunodeficiency virus and pulmonary tuberculosis experienced meaningful declines in lung function on antiretroviral therapy, suggesting a role for lung function in TB-IRIS definitions.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/TuberculosisHIVImmune reconstitution inflammatory syndromePulmonary functionDeclines in lung function after antiretroviral therapy initiation in adults with human immunodeficiency virus and tuberculosis: A potential manifestation of respiratory immune reconstitution inflammatory SyndromeArticleClinical Infectious Diseases